XJPX
6340
Market cap995mUSD
Oct 09, Last price
5,900.00JPY
1D
3.87%
1Q
37.05%
Jan 2017
140.91%
Name
Shibuya Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shibuya Corp. engages in the manufacture and sale of mechatronics systems and packaging plant products. It operates through the following segments: Packaging Plant, Mechatronics Systems, and Agricultural Equipment. The Packaging Plant segment produces and sells washing, sterilization, filling, capping, label sticking, box-making, conveyors, and sealing machines. The Mechatronics Systems segment manufactures and sells laser systems, semiconductor systems, and medical equipment. The Agricultural Equipment segment sells fruit-sorting equipment. The company was founded by Kashichi Shibuya on March 5, 1931 and is headquartered in Kanazawa, Japan.
Key people
Hidetoshi Shibuya
President, Executive President, Chief Executive Officer, Chief Senior Director of Group Business Planning, Representative Director · since 2023
Hewen Bei
Executive Officer, Deputy Chief Director of Finance and Accounting, Director of Accounting · since 2025
Takashi Kawamura
Executive Vice President, Vice President, Chief Director of Finance & Accounting, Deputy Chief Senior Director of Business Planning, Manager of Internal Control & Audit Office, Director · since 2023
Kazuhiro Miyamae
Managing Executive Officer, Deputy Chief Director Finance & Accounting, Director of Finance · since 2023
Munetaka Honda
Executive Vice President, Vice President, Chief Director of General Affairs, Chief Director of Information & Intellectual Property, Deputy Chief Senior Director of Group Business Planning, Director · since 2023
Katsumi Mori
Vice President, Executive Vice President, Chief Senior Director of Mechatronics, Chief Director of Medical Equipment and Production, Deputy Chief Senior Director of Group Corporate Planning, Director · since 2024
Yukinobu Nishino
Senior Managing Executive Officer, Chief Senior Director of Plant Production, Chief Director of Development, Technology Administration, Plant Technology, Validation and Quality, Engineering, Director · since 2025
Takahiro Takamoto
Senior Managing Executive Officer, Chief Director of Operations Management, Deputy Chief Senior Director of Plant Sales · since 2023
Shinji Nakanishi
Managing Executive Officer, Deputy Chief Director of General Affairs, Director of General Affairs in Main General Affairs Unit · since 2023
Takayuki Nishimura
Senior Executive Officer, Deputy Chief Director of Medical Devices in Main Mechatronics Supervision Unit, Senior Director of Production, Director of Manufacturing · since 2025
Yutaka Shimizu
Senior Executive Officer, Deputy Chief Director of Technology Management, Senior Director of Control Technology in Main Plant Technology Unit · since 2025
Akinori Futaki
Senior Managing Executive Officer, Chief Senior Director of Plant Sales, Chief Director of BS Sales, Chief Director of Plant Overseas Sales · since 2023
Ryohei Nakamura
Senior Executive Officer, Chief Director of Plant Overseas Sales, Director of Sales · since 2025
Katsuyasu Matsue
Executive Officer, Deputy Chief Director of Information and Intellectual Property, Director of Management Information System · since 2025
Tatsuhiro Nakata
Executive Officer, Deputy Chief Director of Validation & Quality, Director of Quality Assurance · since 2024
Masaru Nomura
Executive Officer, Deputy Chief Director of Engineering, Director of 1st Technology · since 2025
Kazuhito Tanimoto
Executive Officer, Deputy Chief Director of Regenerative Medicine Systems · since 2024
Masaken Tsunoda
Executive Officer, Deputy Chief Director of Pharmaceutical Equipment Technology, Director of PH Engineering · since 2024
Noriyuki Kondo
Independent Director · since 2022
Masako Osuna
Independent Director · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||